Cargando…

Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation

BACKGROUND: When anti-VEGF (vascular endothelial growth factor) antibody bevacizumab is applied in neoadjuvant treatment of colorectal cancer patients with liver metastasis, 5–6 weeks between last bevacizumab dose and liver resection are currently recommended to avoid complications in wound and live...

Descripción completa

Detalles Bibliográficos
Autores principales:	Starlinger, P, Alidzanovic, L, Schauer, D, Maier, T, Nemeth, C, Perisanidis, B, Tamandl, D, Gruenberger, B, Gruenberger, T, Brostjan, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464762/ https://www.ncbi.nlm.nih.gov/pubmed/22850548 http://dx.doi.org/10.1038/bjc.2012.342

Ejemplares similares

The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance
por: Alidzanovic, Lejla, et al.
Publicado: (2016)

Monocytes with angiogenic potential are selectively induced by liver resection and accumulate near the site of liver regeneration
por: Schauer, Dominic, et al.
Publicado: (2014)

The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy
por: Pereyra, D., et al.
Publicado: (2019)

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
por: Gruenberger, Birgit, et al.
Publicado: (2008)

Deficiency in Thrombopoietin Induction after Liver Surgery Is Associated with Postoperative Liver Dysfunction
por: Haegele, Stefanie, et al.
Publicado: (2015)

Intermediate Monocytes but Not TIE2-Expressing Monocytes Are a Sensitive Diagnostic Indicator for Colorectal Cancer
por: Schauer, Dominic, et al.
Publicado: (2012)

Platelet-Stored Angiogenesis Factors: Clinical Monitoring Is Prone to Artifacts
por: Starlinger, Patrick, et al.
Publicado: (2011)

Perioperative Non-Invasive Indocyanine Green-Clearance Testing to Predict Postoperative Outcome after Liver Resection
por: Haegele, Stefanie, et al.
Publicado: (2016)

Elevated ADAMTS13 Activity is Associated with Poor Postoperative Outcome in Patients Undergoing Liver Resection
por: Haegele, Stefanie, et al.
Publicado: (2018)

Predicting Postoperative Liver Dysfunction Based on Blood‐Derived MicroRNA Signatures
por: Starlinger, Patrick, et al.
Publicado: (2019)

Clinical management of patients with complicated multifocal disease
por: Gruenberger, Thomas
Publicado: (2014)

Thrombocytes Correlate with Lymphangiogenesis in Human Esophageal Cancer and Mediate Growth of Lymphatic Endothelial Cells In Vitro
por: Schoppmann, Sebastian F., et al.
Publicado: (2013)

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
por: Krizova, Deli, et al.
Publicado: (2014)

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
por: Papadopoulos, Nicholas, et al.
Publicado: (2012)

The Effect of Induction Chemotherapy with VEGF Inhibition on Tumor Response in Synchronously Metastasized Potentially Resectable Colorectal Cancer
por: Thonhauser, Rebecca, et al.
Publicado: (2023)

Neutrophil-Mediated Proteolysis of Thrombospondin-1 Promotes Platelet Adhesion and String Formation
por: Seif, Katharina, et al.
Publicado: (2018)

HER 2/neu protein expression in colorectal cancer
por: Schuell, B, et al.
Publicado: (2006)

Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
por: Tsubota, Kinya, et al.
Publicado: (2019)

Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells
por: Rusovici, Raluca, et al.
Publicado: (2011)

Does anti-VEGF bevacizumab improve survival in experimental sepsis?
por: Besnier, Emmanuel, et al.
Publicado: (2017)

Quantification of Cellular Folate Species by LC-MS after Stabilization by Derivatization
por: Schittmayer, Matthias, et al.
Publicado: (2018)

Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?
por: Pfeiffer, Per, et al.
Publicado: (2018)

Integrative metabolomics as emerging tool to study autophagy regulation
por: Stryeck, Sarah, et al.
Publicado: (2017)

Long-tract ileocolic intussusception due to mucinous adenocarcinoma of the ileocecal valve: a case report and literature review
por: Gruenberger, E.H., et al.
Publicado: (2017)

Addressing Glutathione Redox Status in Clinical Samples by Two-Step Alkylation with N-ethylmaleimide Isotopologues
por: Tomin, Tamara, et al.
Publicado: (2020)

Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis
por: Dengler, Mirko, et al.
Publicado: (2017)

VEGF(165)b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
por: Varey, A H R, et al.
Publicado: (2008)

Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF
por: Sharma, Rajesh K., et al.
Publicado: (2010)

Morphological Changes of Cortical and Hippocampal Neurons after Treatment with VEGF and Bevacizumab
por: Latzer, Pauline, et al.
Publicado: (2016)

Blocking VEGF by Bevacizumab Compromises Electrophysiological and Morphological Properties of Hippocampal Neurons
por: Latzer, Pauline, et al.
Publicado: (2019)

Nasal mucus proteome and its involvement in allergic rhinitis
por: Tomazic, Peter Valentin, et al.
Publicado: (2020)

Bilateral Hindfoot Osteonecrosis Associated with Treatment for Cutaneous T-Cell Lymphoma
por: Ricci, Gianni, et al.
Publicado: (2022)

Side effects during chemotherapy predict tumour response in advanced colorectal cancer
por: Schuell, B, et al.
Publicado: (2005)

Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement
por: Taghizadeh, Hossein, et al.
Publicado: (2023)

Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI
por: Guo, J, et al.
Publicado: (2015)

Redox-driven cardioprotective effects of sodium-glucose co-transporter-2 inhibitors: comparative review
por: Hoehlschen, Julia, et al.
Publicado: (2023)

A pharmacokinetic binding model for bevacizumab and VEGF(165) in colorectal cancer patients
por: Panoilia, Eirini, et al.
Publicado: (2015)

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2019)

The Immune Phenotype of Isolated Lymphoid Structures in Non-Tumorous Colon Mucosa Encrypts the Information on Pathobiology of Metastatic Colorectal Cancer
por: Mungenast, Felicitas, et al.
Publicado: (2020)

d-Xylulose kinase from Saccharomyces cerevisiae: Isolation and characterization of the highly unstable enzyme, recombinantly produced in Escherichia coli
por: Pival, Simone L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5f809d7n4glo9691afm6oijg4j